In our study, TCR/BCR immune repertoire profiling reveals the residual alterations in the adaptive immune system of convalescent patients recovering from COVID‐19 6 months after infection, including lymphopenia, reduced diversity, skewed V/J gene usage and B cell repertoire activation. The gene discussed is BCR; the disease is COVID-19.